JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.85B |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.5B |
| 3 |
JPMorgan BetaBuilders Canada ETF
BBCA
|
+$1.21B |
| 4 |
Chevron
CVX
|
+$1.08B |
| 5 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$986M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$3.61B |
| 2 |
Occidental Petroleum
OXY
|
+$1.36B |
| 3 |
Merck
MRK
|
+$913M |
| 4 |
Visa
V
|
+$801M |
| 5 |
AT&T
T
|
+$771M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.95% |
| 2 | Technology | 12.9% |
| 3 | Financials | 12.36% |
| 4 | Healthcare | 9.31% |
| 5 | Consumer Discretionary | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5126
LSB Industries
LXU
$724M
| $33K | ﹤0.01% |
11,892
+2,238
| +23% | +$8.53K |
2016 Q4
10 quarters
|
|
5127
Provident Financial
PROV
$115M
| $33K | ﹤0.01% |
1,609
+73
| +5% | +$1.48K |
2019 Q1
1 quarter
|
|
|
LEVL
5128
DELISTED
Level One Bancorp, Inc. Common Stock
LEVL
| $33K | ﹤0.01% |
1,413
+154
| +12% | +$3.7K |
2018 Q2
4 quarters
|
|
|
ECT
5129
DELISTED
ECA Marcellus Trust 1 Interest
ECT
| $33K | ﹤0.01% |
18,800
| – | – |
2019 Q1
1 quarter
|
|
|
EGPT
5130
DELISTED
VanEck Egypt Index ETF
EGPT
| $33K | ﹤0.01% |
1,066
+100
| +10% | +$3.12K |
2019 Q1
1 quarter
|
|
|
WBK
5131
DELISTED
Westpac Banking Corporation
WBK
| $33K | ﹤0.01% |
1,699
+29
| +2% | +$555 |
2013 Q2
24 quarters
|
|
5132
Comp X International
CIX
$460M
| $32K | ﹤0.01% |
2,089
+614
| +42% | +$9.46K |
2016 Q4
10 quarters
|
|
5133
VanEck Energy Income ETF
EINC
$78.7M
| $32K | ﹤0.01% |
547
-2,594
| -83% | -$155K |
2015 Q4
14 quarters
|
|
5134
First Trust S&P REIT Index Fund
FRI
$183M
| $32K | ﹤0.01% |
1,291
| – | – |
2017 Q3
7 quarters
|
|
5135
iShares Global Financials ETF
IXG
$692M
| $32K | ﹤0.01% |
500
| – | – |
2018 Q4
2 quarters
|
|
5136
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
$2.74B
| $32K | ﹤0.01% |
1,265
| – | – |
2018 Q3
3 quarters
|
|
|
PVBC
5137
DELISTED
Provident Bancorp
PVBC
| $32K | ﹤0.01% |
2,369
+243
| +11% | +$2.93K |
2017 Q4
6 quarters
|
|
5138
Silvercrest Asset Management
SAMG
$84.2M
| $32K | ﹤0.01% |
2,353
+323
| +16% | +$4.51K |
2017 Q4
6 quarters
|
|
5139
Schwab US Large- Cap ETF
SCHX
$74.8B
| $32K | ﹤0.01% |
2,754
+954
| +53% | +$11K |
2018 Q3
3 quarters
|
|
5140
Energous
WATT
$71.3M
| $32K | ﹤0.01% |
13
+4
| +44% | +$11.7K |
2017 Q4
6 quarters
|
|
|
TESS
5141
DELISTED
Tessco Technologies Inc
TESS
| $32K | ﹤0.01% |
+1,699
| New | +$31.1K |
2019 Q2
0 quarters
|
|
5142
Schwab Fundamental US Large Company Index ETF
FNDX
$27.3B
| $31K | ﹤0.01% |
2,394
+618
| +35% | +$7.92K |
2018 Q3
3 quarters
|
|
5143
Schwab Fundamental International Large Company Index ETF
FNDF
$25.5B
| $31K | ﹤0.01% |
1,093
-495
| -31% | -$13.7K |
2018 Q1
5 quarters
|
|
5144
First Trust Nasdaq Bank ETF
FTXO
$251M
| $31K | ﹤0.01% |
1,250
| – | – |
2017 Q1
9 quarters
|
|
5145
Gencor Industries
GENC
$255M
| $31K | ﹤0.01% |
2,495
+348
| +16% | +$4.25K |
2017 Q4
6 quarters
|
|
5146
Information Services Group
III
$284M
| $31K | ﹤0.01% |
9,472
-26,529
| -74% | -$89.5K |
2017 Q4
6 quarters
|
|
5147
Lineage Cell Therapeutics
LCTX
$234M
| $31K | ﹤0.01% |
29,705
+2,170
| +8% | +$2.5K |
2017 Q4
6 quarters
|
|
|
FFNW
5148
DELISTED
First Financial Northwest, Inc
FFNW
| $31K | ﹤0.01% |
2,177
-1,818
| -46% | -$28.5K |
2016 Q4
10 quarters
|
|
|
CHA
5149
DELISTED
China Telecom Corporation, LTD
CHA
| $31K | ﹤0.01% |
626
+501
| +401% | +$25.7K |
2014 Q4
18 quarters
|
|
5150
BioLife Solutions
BLFS
$1.85B
| $30K | ﹤0.01% |
+1,833
| New | +$32K |
2019 Q2
0 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2019 Portfolio in Review
As of Q2 2019, JP Morgan Chase held 6,226 positions worth $511B, up 4.5% from $490B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q2 2019 filing shows 458 new, 2,668 increased, 2,116 reduced and 420 closed positions. Its largest new stake was Corteva: 13,119,143 shares worth $388M. The largest sale was iShares 1-3 Year Treasury Bond ETF, an estimated $3.61B.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, up from 27% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q2 2019 buy was Corteva: 13,119,143 shares worth $388M.
- JP Morgan Chase added most to iShares 0-1 Year Treasury Bond ETF in Q2 2019, an estimated $3.85B increase.
- JP Morgan Chase's biggest Q2 2019 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $3.61B.
- JP Morgan Chase fully exited Goldcorp Inc in Q2 2019, selling an estimated $131M.
- JP Morgan Chase's ten largest holdings make up 16% of its $511B portfolio in Q2 2019.
- JP Morgan Chase opened 458 new positions and closed 420 in Q2 2019.
- JP Morgan Chase's portfolio value rose 4.5% quarter-over-quarter to $511B.
Based on JP Morgan Chase's 13F filing for Q2 2019, filed 7 Aug 2019.